Raymond Briggs CBE includes Parkinson’s UK in his generous legacy Date 30 April 2024 The gift was made in memory of his long-term partner, Liz, who developed Parkinson’s towards the end of her life.
Celebrating International Dance Day Date 29 April 2024 To mark International Dance Day on 29 April, we spoke to the National Dance Company (NDC) Wales about how they're helping the Welsh Parkinson's community take to the floor.
World Parkinson's Day 2024 Date 26 April 2024 Once again our incredible Parkinson's community made their voices heard this World Parkinson's Day. Here's what we achieved, together.
Parkinson's UK invests in potential new drug targeting brain inflammation Date 25 April 2024 We're providing £2.1million through our Virtual Biotech programme to develop a potential new drug which holds promise for protecting brain cells in Parkinson's.
Celebrating World Table Tennis Day Date 23 April 2024 Tuesday 23 April is World Table Tennis Day, a celebration of all things table tennis. We spoke to members of the Parkinson's community about their experiences of playing table tennis and how it helps them to manage their symptoms.
Trial of ondansetron as a treatment for hallucinations in Parkinson's: an update Date 22 April 2024 The TOP HAT trial is closing early and we have an important update on next steps.
Awarding nearly £600,000 to support the next leaders in Parkinson's research Date 11 April 2024 Parkinson’s UK has funded two future leaders in Parkinson’s research who are pushing forward our understanding of the early stages and causes of Parkinson’s.
Gut bacteria transplant may improve Parkinson’s movement symptoms Date 8 April 2024 Early research shows transplanting gut bacteria from healthy individuals to people with Parkinson’s, called a faecal microbiota transplant, is safe and may ease motor symptoms.
Parkinson's community invited to get active with new hybrid workouts Date 5 April 2024 Reach Your Peak is working with Parkinson's UK to deliver new hybrid workouts for people with Parkinson's.
Results from a phase 2 trial of lixisenatide have been published Date 4 April 2024 Lixisenatide, a diabetes drug being investigated for Parkinson’s, shows potential to slow the progression of movement symptoms.
